Hims vs Lemonaid Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Hims beats Lemonaid Health overall, scoring 7.9/10 vs 7.2/10. Hims is more affordable at $199/mo vs $248/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-appr. Choose Lemonaid Health for users who want a flexible membership with broad medication o.

A side-by-side comparison of Hims and Lemonaid Health covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Hims

#12 of 48

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership — alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026) — significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28% — the highest 1-star rate in our table — clustered around subscription/billing complaints.

Visit Hims

Lemonaid Health

#43 of 48

7.2/10

Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).

Visit Lemonaid Health

Feature	Hims	Lemonaid Health
Our Score	7.9/10	7.2/10
Starting Price	$199/mo	$248/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership — but should know going in that Hims' customer-experience signal is weaker than smaller competitors	Users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449)
Ranking	#12	#43

Pros & Cons Compared

Hims

Pros

+Publicly traded company (NYSE: HIMS) — SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
+Polished app and web experience — among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461) — significant real-world adoption.

Cons

−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026) — significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star — the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss) — not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1 — it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
−Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
−Generic high-volume support — large patient base means less personalized attention than smaller competitors.

Lemonaid Health

Pros

+2026 restructure — $49/mo Weight Loss Membership (replaces the old $25/visit model)
+6-month plan discount — compounded tirzepatide drops to $229/mo on a 6-month commitment
+Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
+Established since 2013 with physician-only prescribing and rigorous intake

Cons

−Membership and medication billed separately — the $49/mo number is just the membership, not all-in
−Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high — read as access, not value
−Best compounded pricing requires a 6-month commitment
−The 23andMe acquisition created some uncertainty about the platform's long-term focus

Our Verdict

Hims edges out Lemonaid Health with a score of 7.9/10 vs 7.2/10. If budget is your priority, Hims starts at $199/mo compared to Lemonaid Health's $248/mo. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership — but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Lemonaid Health if you want: users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449).

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hims nor Lemonaid Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review